Non-invasive Diagnosis of Idiopathic Nephrotic Syndromes

Key facts

Sponsor

Assistance Publique - Hôpitaux de Paris

Principal Investigator

Alexandre LAHENS, Dr

Assistance Publique - Hôpitaux de Paris

Enrollment

265 target

Eligibility

18 years · All sexes

Timeline

2025 – 2027

Study locations (1)

• Service de Néphrologie et Dialyses, Hôpital Tenon, Paris, France, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Idiopathic nephrotic syndrome

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGPHASE3NCT05627557
  A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome
  Hoffmann-La Roche
• RECRUITINGNCT04207580
  A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.
  University Hospital, Limoges

See all trials for Idiopathic nephrotic syndrome →